{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:21:47Z","timestamp":1792156907158,"version":"4.4.0"},"reference-count":127,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32360003"],"award-info":[{"award-number":["32360003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hand, foot, and mouth disease (HFMD) is an acute infectious disease caused by human enteroviruses (EVs). EVs are most prevalent in children under five years of age and have the potential to result in herpangina, HFMD, and severe complications, including encephalitis and death. Since the first outbreak was reported in 2008 in Finland, coxsackievirus A6 (CVA6) has spread rapidly and frequently undergone recombination events worldwide, posing a threat to the health of pediatric population around the globe.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim of review<\/jats:title>\n                    <jats:p>The dearth of vaccines and anti-CVA6 drugs hinders the efficient prevention and control of CVA6. However, over the course of the last decade, researchers have endeavored to develop potential vaccine candidates for CVA6 using various pathways. In this study, we present a systematic review of research progress pertaining to the CVA6 vaccines, with a particular emphasis on the most recent advancements in CVA6 vaccine development and evaluation. The objective of this review is to establish a theoretical foundation for the formulation of preventive and control strategies, as well as the development of vaccines against not only CVA6 but also other key serotypes in the future.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key scientific concepts of review<\/jats:title>\n                    <jats:p>The review comprehensively addresses the diverse array of CVA6 vaccine development, encompassing a range of modalities such as inactivated, virus-like particle, and subunit vaccines, among others. A systematic analysis was conducted on animal-based assessments of various CVA6 vaccines, encompassing immunogenicity, protection rate, and cross-immunization as critical evaluation parameters. In light of the recurrent recombination of CVA6 and the evolution of pathogen profiles, the recommendation is made for the future development of multivalent and mRNA vaccines, which hold significant potential in the prevention and control of CVA6 and other major dominant serotypes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1603028","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T01:23:45Z","timestamp":1749173025000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Recent advances on coxsackievirus A6 vaccine research"],"prefix":"10.3389","volume":"16","author":[{"given":"Xianfeng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenglan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1080\/20477724.2024.2400424","article-title":"A review of enterovirus-associated hand-foot and mouth disease: preventive strategies and the need for a global enterovirus surveillance network","volume":"118","author":"Huang","year":"2024","journal-title":"Pathog Glob Health"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(19)30065-3","article-title":"Remaining challenges for prevention and control of hand, foot, and mouth disease","volume":"3","author":"Yu","year":"2019","journal-title":"Lancet Child Adolesc Health"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.81a.13132","article-title":"Hand, foot, and mouth disease: Identifying and managing an acute viral syndrome","volume":"81","author":"Repass","year":"2014","journal-title":"Cleveland Clinic J Medicine"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005266","article-title":"Evolution and emergence of enteroviruses through intra- and inter-species recombination: plasticity and phenotypic impact of modular genetic exchanges in the 5\u2019 Untranslated region","volume":"11","author":"Muslin","year":"2015","journal-title":"PloS Pathog"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3201\/eid1509.090438","article-title":"Coxsackievirus A6 and hand, foot, and mouth disease, Finland","volume":"15","author":"Osterback","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"105691","DOI":"10.1016\/j.jcv.2024.105691","article-title":"Evolution, recombination and geographic spreading of global Coxsackievirus A6","volume":"173","author":"Lu","year":"2024","journal-title":"J Clin Virol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"105498","DOI":"10.1016\/j.meegid.2023.105498","article-title":"Epidemiological and molecular characterization of Coxsackievirus A6 causing hand, foot, and mouth disease in the Philippines, 2012-2017","volume":"114","author":"Foronda","year":"2023","journal-title":"Infect Genet Evol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3390\/v14051078","article-title":"Coxsackievirus A6 recombinant subclades D3\/A and D3\/H were predominant in hand-foot-and-mouth disease outbreaks in the paediatric population, France, 2010-2018","volume":"14","author":"Tomba Ngangas","year":"2022","journal-title":"Viruses"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70342-6","article-title":"Hand, foot, and mouth disease in China, 2008-12: an epidemiological study","volume":"14","author":"Xing","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.811553","article-title":"Surveillance, epidemiology and impact of EV-A71 vaccination on hand, foot, and mouth disease in Nanchang, China, 2010-2019","volume":"12","author":"He","year":"2021","journal-title":"Front Microbiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"100370","DOI":"10.1016\/j.lanwpc.2021.100370","article-title":"Changing epidemiology of hand, foot, and mouth disease in China, 2013-2019: a population-based study","volume":"20","author":"Hong","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"B12","doi-asserted-by":"publisher","first-page":"17028","DOI":"10.1038\/s41598-022-21312-2","article-title":"The spatial-temporal distribution and etiological characteristics of hand-foot-and-mouth disease before and after EV-A71 vaccination in Kunming, China, 2017-2020","volume":"12","author":"Wang","year":"2022","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"104307","DOI":"10.1016\/j.jcv.2020.104307","article-title":"Atypical hand-foot-mouth disease in Belem, Amazon region, northern Brazil, with detection of coxsackievirus A6","volume":"126","author":"Justino","year":"2020","journal-title":"J Clin Virol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcv.2018.11.003","article-title":"Severe atypical hand-foot-and-mouth disease in adults due to coxsackievirus A6: Clinical presentation and phylogenesis of CV-A6 strains","volume":"110","author":"Broccolo","year":"2019","journal-title":"J Clin Virol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"10550","DOI":"10.1038\/srep10550","article-title":"The Epidemiological Study of Coxsackievirus A6 revealing Hand, Foot and Mouth Disease Epidemic patterns in Guangdong, China","volume":"5","author":"Zeng","year":"2015","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.v30.2","article-title":"A review and meta-analysis of the epidemiology and clinical presentation of coxsackievirus A6 causing hand-foot-mouth disease in China and global implications","volume":"30","author":"Zhao","year":"2020","journal-title":"Rev Med Virol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1251683","article-title":"Surveillance, epidemiology, and impact of the coronavirus disease 2019 interventions on the incidence of enterovirus infections in Nanchang, China, 2010-2022","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Microbiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12879-020-04992-x","article-title":"Co-circulation of coxsackieviruses A-6, A-10, and A-16 causes hand, foot, and mouth disease in Guangzhou city, China","volume":"20","author":"Xie","year":"2020","journal-title":"BMC Infect Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac426","article-title":"The picornaviridae family: knowledge gaps, animal models, countermeasures, and prototype pathogens","volume":"228","author":"Andino","year":"2023","journal-title":"J Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/s42003-022-03863-2","article-title":"Cryo-electron microscopy and image classification reveal the existence and structure of the coxsackievirus A6 virion","volume":"5","author":"Buttner","year":"2022","journal-title":"Commun Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1128\/MRA.01449-19","article-title":"Genome sequence of a human coxsackievirus A6 strain isolated from a severe hand, foot, and mouth disease case in Qingdao, China, in 2017","volume":"9","author":"Su","year":"2020","journal-title":"Microbiol resource announcements"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01257-17","article-title":"A 3.0-angstrom resolution cryo-electron microscopy structure and antigenic sites of coxsackievirus A6-like particles","volume":"92","author":"Chen","year":"2018","journal-title":"J Virol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.3.1941-1948.1999","article-title":"Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification","volume":"73","author":"Oberste","year":"1999","journal-title":"J Virol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41467-017-00477-9","article-title":"Atomic structures of Coxsackievirus A6 and its complex with a neutralizing antibody","volume":"8","author":"Xu","year":"2017","journal-title":"Nat Commun"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00200-14","article-title":"Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development","volume":"88","author":"Gong","year":"2014","journal-title":"J Virol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/1471-2334-11-346","article-title":"An outbreak of coxsackievirus A6 hand, foot, and mouth disease associated with onychomadesis in Taiwan, 2010","volume":"11","author":"Wei","year":"2011","journal-title":"BMC Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.7883\/yoken.JJID.2018.532","article-title":"An epidemic of hand, foot, and mouth disease caused by coxsackievirus A6 in Osaka city, Japan, in 2017","volume":"72","author":"Kartbayashi","year":"2019","journal-title":"Japanese J Infect Diseases"},{"key":"B28","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3390\/v16030476","article-title":"Epidemiological and genetic characterization of coxsackievirus A6-associated hand, foot, and mouth disease in Gwangju, South Korea, in 2022","volume":"16","author":"Lee","year":"2024","journal-title":"Viruses-Basel"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3201\/eid2404.171298","article-title":"Emerging coxsackievirus A6 causing hand, foot and mouth disease, Vietnam","volume":"24","author":"Nguyen To","year":"2018","journal-title":"Emerging Infect Diseases"},{"key":"B30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/v15010073","article-title":"Evolutionary and genetic recombination analyses of coxsackievirus A6 variants associated with hand, foot, and mouth disease outbreaks in Thailand between 2019 and 2022","volume":"15","author":"Puenpa","year":"2022","journal-title":"Viruses"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.47665\/tb.38.1.026","article-title":"Detection of enteroviruses during a 2018 hand, foot and mouth disease outbreak in Malaysia","volume":"38","author":"Lee","year":"2021","journal-title":"Trop Biomed"},{"key":"B32","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3390\/microorganisms12030490","article-title":"Emergence of recombinant subclade D3\/Y in coxsackievirus A6 strains in hand-foot-and-mouth disease (HFMD) outbreak in India, 2022","volume":"12","author":"Tikute","year":"2024","journal-title":"Microorganisms"},{"key":"B33","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3390\/v13050781","article-title":"Surveillance for enteroviruses associated with hand, foot, and mouth disease, and other mucocutaneous symptoms in Spain, 2006-2020","volume":"13","author":"Mart\u00ednez-L\u00f3pez","year":"2021","journal-title":"Viruses"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1186\/s12889-024-20909-8","article-title":"Clinical, aetiological, and epidemiological studies of outpatient cases of hand, foot, and mouth disease in Chengdu, China, from 2019 to 2022: a retrospective study","volume":"24","author":"Xia","year":"2024","journal-title":"BMC Public Health"},{"key":"B35","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.1038\/s41598-017-05618-0","article-title":"Persistent circulation of Coxsackievirus A6 of genotype D3 in mainland of China between 2008 and 2015","volume":"7","author":"Song","year":"2017","journal-title":"Sci Rep"},{"key":"B36","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2217\/fmb-2018-0336","article-title":"Recombinant CV-A6 strains related to hand-foot-mouth disease and herpangina at primary care centers (Barcelona, Spain)","volume":"14","author":"Andres","year":"2019","journal-title":"Future Microbiol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24798","article-title":"Characterization of genome sequences and clinical features of coxsackievirus A6 strains collected in Hyogo, Japan in 1999-2013","volume":"89","author":"Ogi","year":"2017","journal-title":"J Med Virol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e59604","DOI":"10.2196\/59604","article-title":"Molecular evolutionary dynamics of coxsackievirus A6 causing hand, foot, and mouth disease from 2021 to 2023 in China: genomic epidemiology study","volume":"10","author":"Chen","year":"2024","journal-title":"JMIR Public Health Surveill"},{"key":"B39","doi-asserted-by":"publisher","first-page":"105068","DOI":"10.1016\/j.meegid.2021.105068","article-title":"Genome-wide population structure inferences of human coxsackievirus-A; insights the genotypes diversity and evolution","volume":"95","author":"Khan","year":"2021","journal-title":"Infect Genet Evol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s10123-021-00164-2","article-title":"Molecular epidemiology and recombination of Enterovirus A71 in mainland China from 1987 to 2017","volume":"24","author":"Zhou","year":"2021","journal-title":"Int Microbiol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s11262-014-1152-y","article-title":"Recombination among human non-polio enteroviruses: implications for epidemiology and evolution","volume":"50","author":"Kyriakopoulou","year":"2015","journal-title":"Virus Genes"},{"key":"B42","doi-asserted-by":"publisher","first-page":"100284","DOI":"10.1016\/j.lanwpc.2021.100284","article-title":"Immunogenicity and safety of inactivated enterovirus A71 vaccines in children aged 6\u201335 months in China: a non-inferiority, randomised controlled trial","volume":"16","author":"Li","year":"2021","journal-title":"Lancet Reg Health West Pac"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2024.09.020","article-title":"Effectiveness of the enterovirus A71 vaccine on hand, foot, and mouth disease: a real-world study in China","volume":"31","author":"Liu","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China","volume":"370","author":"Zhu","year":"2014","journal-title":"N Engl J Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.01.048","article-title":"Post-marketing safety surveillance for inactivated Enterovirus 71 vaccines in Jiangsu, China from 2017 to 2019","volume":"39","author":"Gao","year":"2021","journal-title":"Vaccine"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e70201","DOI":"10.1002\/jmv.70201","article-title":"The immunogenicity of coxsackievirus A6 (D3a sub-genotype) virus-like particle and mRNA vaccines","volume":"97","author":"Lu","year":"2025","journal-title":"J Med Virol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12985-024-02618-1","article-title":"Construction of a Vero cell line expression human KREMEN1 for the development of CVA6 vaccines","volume":"22","author":"Zhang","year":"2025","journal-title":"Virol J"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.bsheal.2023.11.001","article-title":"Preparation and immunoprotective effects of a virus-like particle candidate vaccine of the dominant epidemic D3 genotype coxsackievirus A6 in China","volume":"6","author":"Li","year":"2023","journal-title":"Biosaf Health"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.04.087","article-title":"Immunogenicity and immunodominant linear B-cell epitopes of a new DNA-based tetravalent vaccine against four major enteroviruses causing hand, foot, and mouth disease","volume":"42","author":"Bello","year":"2024","journal-title":"Vaccine"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2022.2119166","article-title":"A mouse-adapted CVA6 strain exhibits neurotropism and triggers systemic manifestations in a novel murine model","volume":"11","author":"Li","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2021.1906755","article-title":"Efficacy of a coxsackievirus A6 vaccine candidate in an actively immunized mouse model","volume":"10","author":"Qian","year":"2021","journal-title":"Emerg Microbes Infect"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.665197","article-title":"A 10-day-old murine model of coxsackievirus A6 infection for the evaluation of vaccines and antiviral drugs","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.03.023","article-title":"Development of a multivalent enterovirus subunit vaccine based on immunoinformatic design principles for the prevention of HFMD","volume":"38","author":"Deng","year":"2020","journal-title":"Vaccine"},{"key":"B54","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41426-018-0094-1","article-title":"A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity","volume":"7","author":"Zhang","year":"2018","journal-title":"Emerging Microbes Infections"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.05.005","article-title":"The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease","volume":"36","author":"Lim","year":"2018","journal-title":"Vaccine"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.09.069","article-title":"Characterization of an inactivated whole-virus bivalent vaccine that induces balanced protective immunity against coxsackievirus A6 and A10 in mice","volume":"36","author":"Zhang","year":"2018","journal-title":"Vaccine"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02450-16","article-title":"A neonatal murine model of coxsackievirus A6 infection for evaluation of antiviral and vaccine efficacy","volume":"91","author":"Zhang","year":"2017","journal-title":"J Virol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.antiviral.2016.02.008","article-title":"Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles","volume":"129","author":"Liu","year":"2016","journal-title":"Antiviral Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.06.028","article-title":"Virus-like particle-based vaccine against coxsackievirus A6 protects mice against lethal infections","volume":"34","author":"Shen","year":"2016","journal-title":"Vaccine"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2016.06.004","article-title":"Yeast-produced recombinant virus-like particles of coxsackievirus A6 elicited protective antibodies in mice","volume":"132","author":"Zhou","year":"2016","journal-title":"Antiviral Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2016.08.025","article-title":"A neonatal mouse model for the evaluation of antibodies and vaccines against coxsackievirus A6","volume":"134","author":"Yang","year":"2016","journal-title":"Antiviral Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3390\/v7112916","article-title":"Efficacy of a trivalent hand, foot, and mouth disease vaccine against enterovirus 71 and coxsackieviruses A16 and A6 in mice","volume":"7","author":"Caine","year":"2015","journal-title":"Viruses-Basel"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.06.110","article-title":"Cell substrates for the production of viral vaccines","volume":"33","author":"Aubrit","year":"2015","journal-title":"Vaccine"},{"key":"B64","doi-asserted-by":"publisher","first-page":"199268","DOI":"10.1016\/j.virusres.2023.199268","article-title":"Effects of glycine 64 substitutions in RNA-dependent RNA polymerase on ribavirin sensitivity and pathogenicity of coxsackievirus A6","volume":"339","author":"Wang","year":"2024","journal-title":"Virus Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e2407241","DOI":"10.1002\/advs.202407241","article-title":"Viral live-attenuated vaccines (LAVs): past and future directions","volume":"12","author":"Tang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B66","doi-asserted-by":"publisher","first-page":"131802","DOI":"10.1016\/j.ijbiomac.2024.131802","article-title":"Genome editing and its role in vaccine, diagnosis, and therapeutic advancement","volume":"269","author":"Bisht","year":"2024","journal-title":". Int J Biol Macromol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12033-012-9598-4","article-title":"Construction and characterization of virus-like particles: a review","volume":"53","author":"Zeltins","year":"2013","journal-title":"Mol Biotechnol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-014-5639-1","article-title":"Virus-like particles in picornavirus vaccine development","volume":"98","author":"Dong","year":"2014","journal-title":"Appl Microbiol Biotechnol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbt.2017.07.010","article-title":"Production of virus-like particles for vaccines","volume":"39","author":"Fuenmayor","year":"2017","journal-title":"N Biotechnol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10616-023-00598-8","article-title":"Construction of a novel kinetic model for the production process of a CVA6 VLP vaccine in CHO cells","volume":"76","author":"Xing","year":"2024","journal-title":"Cytotechnology"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012873","article-title":"Enterovirus-like particles encapsidate RNA and exhibit decreased stability due to lack of maturation","volume":"21","author":"Kuijpers","year":"2025","journal-title":"PloS Pathog"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu648","article-title":"Raising expectations for subunit vaccine","volume":"211","author":"Schiller","year":"2015","journal-title":"J Infect Dis"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201200487","article-title":"Modern subunit vaccines: development, components, and research opportunities","volume":"8","author":"Moyle","year":"2013","journal-title":"ChemMedChem"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.01.017","article-title":"Protein subunit vaccines: Promising frontiers against COVID-19","volume":"366","author":"Chavda","year":"2024","journal-title":"J Control Release"},{"key":"B75","doi-asserted-by":"publisher","first-page":"168297","DOI":"10.1016\/j.jmb.2023.168297","article-title":"DNA vaccines: history, molecular mechanisms and future perspectives","volume":"435","author":"Pagliari","year":"2023","journal-title":"J Mol Biol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.2003.01140.x","article-title":"DNA vaccines: a review","volume":"253","author":"Liu","year":"2003","journal-title":"J Intern Med"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"B78","doi-asserted-by":"publisher","first-page":"Fso300","DOI":"10.4155\/fsoa-2017-0151","article-title":"Latest development on RNA-based drugs and vaccines","volume":"4","author":"Lundstrom","year":"2018","journal-title":"Future Sci OA"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-024-01042-y","article-title":"mRNA vaccines for infectious diseases - advances, challenges and opportunities","volume":"23","author":"Pardi","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"B80","doi-asserted-by":"publisher","first-page":"abm0829","DOI":"10.1126\/science.abm0829","article-title":"mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern","volume":"374","author":"Goel","year":"2021","journal-title":"Science"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-025-00521-0","article-title":"A capless hairpin-protected mRNA vaccine encoding the full-length Influenza A hemagglutinin protects mice against a lethal Influenza A infection","author":"Solodushko","year":"2025","journal-title":"Gene Ther"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2024.12.032","article-title":"Low-inflammatory lipid nanoparticle-based mRNA vaccine elicits protective immunity against H5N1 influenza virus with reduced adverse reactions","volume":"33","author":"Kawai","year":"2025","journal-title":"Mol Ther"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2377606","DOI":"10.1080\/22221751.2024.2377606","article-title":"A long-term stable cold-chain-friendly HIV mRNA vaccine encoding multi-epitope viral protease cleavage site immunogens inducing immunogen-specific protective T cell immunity","volume":"13","author":"Mandal","year":"2024","journal-title":"Emerg Microbes Infect"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae035","article-title":"Safety, tolerability, and immunogenicity of an mRNA-based respiratory syncytial virus vaccine in healthy young adults in a phase 1 clinical trial","volume":"230","author":"Shaw","year":"2024","journal-title":"J Infect Dis"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive immunity to SARS-coV-2 and COVID-19","volume":"184","author":"Sette","year":"2021","journal-title":"Cell"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1038\/s41467-023-38751-8","article-title":"An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants","volume":"14","author":"Tai","year":"2023","journal-title":"Nat Commun"},{"key":"B87","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12943-021-01348-0","article-title":"mRNA therapeutics in cancer immunotherapy","volume":"20","author":"Beck","year":"2021","journal-title":"Mol Cancer"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcpa.2007.04.014","article-title":"The nature and consequences of intra- and inter-vaccine interference","author":"Vidor","year":"2007","journal-title":"J Comp Pathol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.906275","article-title":"6-valent virus-like particle-based vaccine induced potent and sustained immunity against noroviruses in mice","volume":"13","author":"Hou","year":"2022","journal-title":"Front Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.celrep.2018.09.029","article-title":"B cell competition for restricted T cell help suppresses rare-epitope responses","volume":"25","author":"Woodruff","year":"2018","journal-title":"Cell Rep"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3390\/vaccines9101074","article-title":"T cell\/B cell interactions in the establishment of protective immunity","volume":"9","author":"Ritzau-Jost","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02874","article-title":"Adjuvants enhancing cross-presentation by dendritic cells: the key to more effective vaccines","volume":"9","author":"Ho","year":"2018","journal-title":"Front Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2422528122","article-title":"Antigen mobility regulates the dynamics and precision of antigen capture in the B cell immune synapse","volume":"122","author":"McArthur","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2079346","DOI":"10.1080\/21645515.2022.2079346","article-title":"Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvants","volume":"18","author":"Bajoria","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.700191","article-title":"Characterization of coxsackievirus A6 strains isolated from children with hand, foot, and mouth disease","volume":"11","author":"Liu","year":"2021","journal-title":"Front Cell Infection Microbiol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.12.065","article-title":"Phylogenetic and antigenic analyses of coxsackievirus A6 isolates in Yamagata, Japan between 2001 and 2017","volume":"37","author":"Mizuta","year":"2019","journal-title":"Vaccine"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2322671","DOI":"10.1080\/22221751.2024.2322671","article-title":"A screening study on the detection strain of Coxsackievirus A6: the key to evaluating neutralizing antibodies in vaccines","volume":"13","author":"Gao","year":"2024","journal-title":"Emerg Microbes Infect"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2164140","DOI":"10.1080\/21645515.2022.2164140","article-title":"Establishment of the 1st Chinese national standard for CA6 neutralizing antibody","volume":"19","author":"Wang","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"B99","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3390\/v15020511","article-title":"Coxsackievirus A6 infection causes neurogenic pathogenesis in a neonatal murine model","volume":"15","author":"Sun","year":"2023","journal-title":"Viruses"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2014.942288","article-title":"Immune responses in neonates","volume":"10","author":"Basha","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-00857-2","article-title":"Naturalizing mouse models for immunology","volume":"22","author":"Graham","year":"2021","journal-title":"Nat Immunol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"110268","DOI":"10.1016\/j.virol.2024.110268","article-title":"Establishment of a rhesus macaque model for coxsackievirus A6 infection: Pilot study to evaluate infection initiated through the respiratory or digestive track","volume":"601","author":"Duan","year":"2025","journal-title":"Virology"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1101\/2023.02.23.529651","article-title":"A novel adjuvant formulation induces robust Th1\/Th17 memory and mucosal recall responses in Non-Human Primates","author":"Woodworth","year":"2023","journal-title":"bioRxiv"},{"key":"B104","doi-asserted-by":"publisher","first-page":"6664","DOI":"10.1038\/s41467-024-50339-4","article-title":"Non-human primate model of long-COVID identifies immune associates of hyperglycemia","volume":"15","author":"Palmer","year":"2024","journal-title":"Nat Commun"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2021.1934558","article-title":"A practical method for evaluating the in vivo efficacy of EVA-71 vaccine using a hSCARB2 knock-in mouse model","volume":"10","author":"Wu","year":"2021","journal-title":"Emerg Microbes Infect"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit448","article-title":"Humoral immunity in humanized mice: a work in progress","author":"Seung","year":"2013","journal-title":"J Infect Dis"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S363995","article-title":"Induction of trained immunity protects neonatal mice against microbial sepsis by boosting both the inflammatory response and antimicrobial activity","volume":"15","author":"Zhou","year":"2022","journal-title":"J Inflammation Res"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1101\/2023.01.11.523616","article-title":"Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection","volume":"9","author":"Baldeon Vaca","year":"2023","journal-title":"Sci Adv"},{"key":"B109","doi-asserted-by":"publisher","first-page":"113928","DOI":"10.1016\/j.addr.2021.113928","article-title":"Advancedoral vaccine delivery strategies for improving the immunity","volume":"177","author":"Zhang","year":"2021","journal-title":"Adv Drug Delivery Rev"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/s41467-021-21665-8","article-title":"Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques","volume":"12","author":"Tan","year":"2021","journal-title":"Nat Commun"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2021.1902245","article-title":"Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates","volume":"10","author":"He","year":"2021","journal-title":"Emerg Microbes Infect"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.877845","article-title":"Prospects on repurposing a live attenuated vaccine for the control of unrelated infections","volume":"13","author":"Seo","year":"2022","journal-title":"Front Immunol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.virs.2024.05.005","article-title":"DNA vaccine prime and replicating vaccinia vaccine boost induce robust humoral and cellular immune responses against MERS-CoV in mice","volume":"39","author":"Shen","year":"2024","journal-title":"Virol Sin"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1332939","article-title":"The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects","volume":"15","author":"Lu","year":"2024","journal-title":"Front Immunol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.01.002","article-title":"An inoculation site-retained mRNA vaccine induces robust immune responses against SARS-CoV-2 variants","volume":"366","author":"Huang","year":"2024","journal-title":"J Control Release"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2023.01.006","article-title":"Advanced subunit vaccine delivery technologies: From vaccine cascade obstacles to design strategies","volume":"13","author":"Hou","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"B117","doi-asserted-by":"publisher","first-page":"15612","DOI":"10.1038\/s41598-022-19993-w","article-title":"Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cells","volume":"12","author":"Shimizu","year":"2022","journal-title":"Sci Rep"},{"key":"B118","doi-asserted-by":"publisher","first-page":"112650","DOI":"10.1016\/j.biopha.2022.112650","article-title":"Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine","volume":"147","author":"Nguyen","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-015-0350-4","article-title":"Comparative safety of vaccine adjuvants: A summary of current evidence and future needs","volume":"38","author":"Petrovsky","year":"2015","journal-title":"Drug Saf"},{"key":"B120","doi-asserted-by":"publisher","first-page":"126653","DOI":"10.1016\/j.vaccine.2024.126653","article-title":"Immunogenicity and safety of live attenuated influenza vaccine in children aged 3\u201317 years in China","volume":"46","author":"Ai","year":"2025","journal-title":"Vaccine"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-056021","article-title":"Safety of live-attenuated vaccines in children exposed to biologic response modifiers in utero","volume":"150","author":"Zerbo","year":"2022","journal-title":"Pediatrics"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.03.040","article-title":"Biosafety of DNA vaccines: New generation of DNA vectors and current knowledge on the fate of plasmids after injection","volume":"28","author":"Faurez","year":"2010","journal-title":"Vaccine"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2016.60620","article-title":"Could aluminum be a new hidden allergen in type 1 hypersensitivity reactions when used as a drug additive","volume":"33","author":"Kutlu","year":"2016","journal-title":"Postepy Dermatol Alergol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2015.09.009","article-title":"Aluminum induces inflammatory and proteolytic alterations in human monocytic cell line","volume":"152","author":"Ligi","year":"2015","journal-title":"J Inorg Biochem"},{"key":"B125","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1208\/s12249-018-1254-2","article-title":"Stability of vaccines","volume":"20","author":"Dumpa","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2022.02.001","article-title":"Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine","volume":"30","author":"Muramatsu","year":"2022","journal-title":"Mol Ther"},{"key":"B127","doi-asserted-by":"publisher","first-page":"17359","DOI":"10.1038\/s41598-023-44644-z","article-title":"Molecular evolutionary dynamics of enterovirus A71, coxsackievirus A16 and coxsackievirus A6 causing hand, foot and mouth disease in Thailand, 2000-2022","volume":"13","author":"Noisumdaeng","year":"2023","journal-title":"Sci Rep"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1603028\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T01:23:46Z","timestamp":1749173026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1603028\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":127,"alternative-id":["10.3389\/fimmu.2025.1603028"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1603028","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"article-number":"1603028"}}